Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
101.00    -0.50 (-0.49%)
Bid:
100.00
Ask:
102.00
Spread: 2.00 (2.00%)
Market Cap: £60.13m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

2024 AGM Voting Update Statement

16 Jun 2025 07:00

RNS Number : 9564M
Crystal Amber Fund Limited
16 June 2025
 

 

 

16 June 2025

 

Crystal Amber Fund Limited

("Crystal Amber Fund", the "Company" or the "Fund")

 

2024 AGM Voting Update Statement

 

At the Company's Annual General Meeting ("AGM") held on 13 December 2024, the Company received the following negative votes (as a proportion of the total votes cast) in respect of the following resolutions:

 

Resolution

%

2. Directors remuneration report

31.75

5. To re-elect Chris Waldron

31.74

6. To re-elect Fred Hervouet

31.73

7. To re-elect Jane Le Maitre

31.73

 

These against votes were detailed in the Company's RNS Announcement of 13 December 2024 together with the details of the proxy votes for the AGM.

 

At the time of the AGM, the Company was not aware of any attempts by shareholders that voted against the resolutions to make contact with the Company regarding those resolutions. The Fund has since identified dissenting shareholders and has contacted the substantial dissenting shareholder to seek their views. The Fund will provide further updates once discussions are concluded or any necessary action taken.

 

A full explanation of the Company's performance is provided in the Chairman's statement of the 2024 Annual Report.

 

The full text of all the resolutions can be found in the Company's Annual Report and Accounts, which is available for viewing on the Company's website, www.crystalamber.com/aimrule/documents.

 

 

For further enquiries please contact:

 

Crystal Amber Fund Limited

Chris Waldron (Chairman)

Tel: 01481 742 742

www.crystalamber.com

 

Allenby Capital Limited - Nominated Adviser

Jeremy Porter/ Dan Dearden-Williams

Tel: 020 3328 5656

 

Winterflood Investment Trusts - Broker

Joe Winkley/Neil Langford

Tel: 020 3100 0160

 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Richard Bernstein

Tel: 020 7478 9080

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFAMMTMTIBTTA
Date   Source Headline
10th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Feb 20255:11 pmRNSForm 8.3 - De La Rue plc
6th Feb 20255:32 pmRNSTransaction in Own Shares and Total Voting Rights
6th Feb 202510:56 amRNSHolding(s) in Company
5th Feb 20255:18 pmRNSTransaction in Own Shares and Total Voting Rights
5th Feb 20255:16 pmRNSForm 8.3 - De La Rue plc - Replacement
4th Feb 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Feb 202511:30 amRNSForm 8.3 - De La Rue plc
3rd Feb 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
31st Jan 20255:44 pmRNSTotal Voting Rights
31st Jan 20252:04 pmRNSHolding(s) in Company
30th Jan 20255:43 pmRNSForm 8.3 - De La Rue plc
30th Jan 20255:41 pmRNSTransaction in Own Shares and Total Voting Rights
30th Jan 20258:52 amRNSForm 8.3 - De La Rue plc
30th Jan 20257:27 amRNSTransaction in Own Shares and Total Voting Rights
29th Jan 20257:00 amRNSShare Buyback Programme
28th Jan 20256:24 pmRNSTransaction in Own Shares and Total Voting Rights
28th Jan 20255:28 pmRNSForm 8.3 - De La Rue plc
28th Jan 20259:45 amRNSTransaction in Own Shares and TVR - Replacement
28th Jan 20259:45 amRNSTransaction in Own Shares and TVR - Replacement
28th Jan 20258:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20254:56 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Jan 20252:10 pmRNSMonthly Net Asset Value
21st Jan 20257:00 amRNSForm 8.3 - De La Rue plc
20th Jan 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20257:00 amRNSForm 8.3 - De La Rue plc
17th Jan 20257:00 amRNSForm 8.3 - De La Rue plc
16th Jan 202511:00 amRNSForm 8.3 - De La Rue plc
15th Jan 20255:45 pmRNSTransaction in Own Shares and Total Voting Rights
13th Jan 20256:23 pmRNSConversion of loan notes in Morphic - Replacement
13th Jan 20257:00 amRNSConversion of loan notes in Morphic Medical Inc.
9th Jan 20255:46 pmRNSTransaction in Own Shares and Total Voting Rights
8th Jan 202510:45 amRNSForm 8.3 - De La Rue plc
27th Dec 20247:00 amRNSForm 8.3 - De La Rue plc
19th Dec 202412:00 pmRNSMonthly Net Asset Value
13th Dec 202410:58 amRNSResult of AGM
3rd Dec 20247:00 amRNSFurther investment into Morphic Medical Inc
19th Nov 20244:50 pmRNSMonthly Net Asset Value
18th Nov 20242:58 pmRNSMonthly Net Asset Value
13th Nov 20247:00 amRNSPosting of Annual Report and Notice of AGM
12th Nov 20247:00 amRNSFinal Results
28th Oct 20242:23 pmRNSResult of Extraordinary General Meeting
9th Oct 20247:00 amRNSProposed B share scheme and notice of GM
1st Oct 20241:24 pmRNSMonthly Net Asset Value
11th Sep 20241:11 pmRNSMonthly Net Asset Value
30th Aug 20245:30 pmRNSTotal Voting Rights
23rd Aug 20249:04 amRNSHolding(s) in Company
20th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20244:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.